Star Imaging IPO Listing at 0% Premium at ₹142 Per Share
Posted by : sachet | Mon Aug 18 2025

Star Imaging IPO listing: The Star Imaging IPO was subscribed 5.67 times till its closing. In this subscription, 12.85 times were received by the qualified institutional buyers (QIBs) and 4.83 times by non-institutional investors (NIIs). The retail quota of the issue was subscribed to 31.23%. Before delving deeper into the topic, go through the details of the Star Imaging IPO.
Star Imaging
On the BSE and SME platform, Star Imaging Limited is listed at ₹142 per share at a premium of 0% against the issue price of ₹142 per share.
Star Imaging IPO Details
Star Imaging IPO: It is a bookbuilding IPO of ₹69.47 crore, comprising a fresh issue of 39.20 lakh shares and the offer for sale of 9.72 lakh shares. The issue will be listed on BSE and SME on its tentative listing date, 18th August 2025. The Star Imaging IPO date is fixed between 8th August 2025 and 12th August 2025. The face value of Star Imaging IPO shares stands at ₹10 per share, and the IPO price band is set at ₹142 per share.
IPO Open Date | 8th August 2025 |
IPO Close Date | 12th August 2025 |
IPO Allotment Date | 12th August 2025 |
Refund Initiation | 14th August 2025 |
Issue Size | 48,92,000 shares(aggregating up to ₹69.47 Cr) |
Fresh Issue | 34,40,000 shares(aggregating up to ₹48.85 Cr) |
Offer for Sale | 9,72,000 shares of ₹10(aggregating up to ₹13.80 Cr) |
Face Value | ₹10 per share |
Lot Size | 1,000 Shares |
Issue Price Band | ₹135 to ₹140 per share |
Issue Type | Bookbuilding IPO |
Listing At | BSE & SME |
Listing Date | 18th August 2025 |
About Star Imaging IPO
Star Imaging & Path Lab Limited was incorporated in 2004. Star Imaging and Path Lab Limited is a healthcare company that operates in diagnostic imaging & pathology centres, offering various services, including MRI, CT, X-ray, Ultrasound, and laboratory services. The company’s focus is to provide high-quality healthcare accessible in semi-urban and suburban areas. Company. Star Imaging & Path Lab Limited has raised funds through its IPO for the expansion of healthcare services and to install modern equipment.
Star Imaging Limited Financials
The company’s financial analysis is essential before applying for the Star Imaging IPO. Look at the table to learn about Star Imaging Limited’s financials.
Year Ended | 31st March 2025 (in cr.) | 31st March 2024 (in cr.) | 31st March 2023 (in cr.) |
Assets | 98.16 | 81.64 | 61.23 |
Revenue | 83.79 | 79.97 | 58.68 |
Profit After Tax | 15.96 | 12.45 | 0.58 |
EBITDA | 28.60 | 22.34 | 5.81 |
Net Worth | 47.15 | 31.35 | 18.93 |
Reserve and surplus | 33.65 | 29.85 | 17.43 |
Total Borrowing | 32.73 | 30.64 | 26.56 |
Explanation
Star Imaging Limited’s revenue increased by 5% from ₹79.97 crores in March 2024 to ₹84.79 crores in March 2025. Moreover, the company’s PAT increased by 28% from ₹12.45 crores to ₹15.96 crores. Investors can analyse other relevant factors and make a decision accordingly.
Recent Articles
Max Healthcare Q1 Results FY26: Q1 PAT Rises 30.35% to ₹307.97 Crore; Revenue Up 31.41% YoY
Minda Corporation Q1 Results FY26: Q1 PAT Rises 1.73% to ₹65.31 Crore; Revenue Up 16.23% YoY
Bharat Dynamics Q1 Results FY26: Q1 PAT Rises 154.30% to ₹18.35 Crore; Revenue Up 29.69% YoY
Elitecon International Q1 Results FY26: Q1 PAT Rises 349.99% to ₹20.41 Crore; Revenue Up 301.98% YoY
Elgi Equipments Q1 Results FY26: Q1 PAT Rises 17.58% to ₹85.60 Crore; Revenue Up 8.19% YoY
Aavas Financier Q1 Results FY26: Q1 PAT Rises 10.41% to ₹139.23 Crore; Revenue Up 15.70% YoY
Related Posts
P/E Vs P/B Ratio | Everything You Should Know in 2025
Nava Q1 Results FY26: Q1 PAT Falls 13.39% to ₹308.03 Crore; Revenue Down 2.38% YoY
Vikram Solar IPO GMP & Review: Apply or Avoid?
LGT Business Connextions IPO GMP & Review: Apply or Avoid?
Gem Aromatics IPO GMP & Review: Apply or Avoid?
